This study was conceived by FF, RFG, SZ and AJG All authors prov

This study was conceived by FF, RFG, SZ and AJG. All authors provided substantial contributions to the design of the study. AJG, PB, PG and MT were involved in the study implementation. CL, CD and MHR were involved

in the interpretation of the results. The first draft of the manuscript was written by AJG and RFG. All authors contributed to the writing of the manuscript and agree with the results and conclusions. “
“Herpes zoster (shingles) results when there is reactivation of latent varicella zoster virus after a primary episode of chickenpox. Modelling studies have suggested that the introduction see more of mass vaccination programs against varicella might, over time, lead to an increase in rates of herpes zoster (shingles) [1] because of a lack of immunological boosting due to exposure to varicella virus. Changes in shingles epidemiology DNA-PK inhibitor might be apparent within 10 years of implementation of a varicella (chickenpox) vaccination program [1], [2], [3], [4] and [5]. Varicella vaccines were licensed in Canada in 1998 but initially were not publicly funded

in any province or territory. Alberta became the second Canadian province (after Prince Edward Island) to introduce a publicly funded varicella vaccination program. The publicly funded Alberta program targeted special groups (e.g., healthcare workers and children

in grade 5 who did not have a prior history of chickenpox, shingles or chickenpox vaccination) beginning Rutecarpine in spring 2001 [6]. Starting in July 2001, a single dose of chickenpox vaccine was added to the routine immunization schedule for all children one year of age (i.e., administered at age 12 months); in spring 2002 a single dose of chickenpox vaccine was also offered to all pre-schoolers born on or after January 1, 1997 (catch-up). The routine vaccination schedule for Modulators infants in Alberta has thus included a single dose of chickenpox vaccine to be given at age 12 months since 2001 and the programme gave rise to a dramatic increase in vaccine uptake. Chickenpox vaccine coverage was less than 5% in 2001, the last year in which vaccine was available only by private purchase. It jumped to 60% in 2002 (first year of publicly funded vaccine for routine childhood vaccination schedule). In 2005 and in every subsequent year, it exceeded 80% (Alberta Health, unpublished data). Alberta introduced a second dose of chickenpox vaccine for children aged 4–6 years into the routine childhood vaccination schedule in August 2012 [7]. It has been shown that publicly funded varicella immunization programs in Canada and the United States have resulted in a reduction in chickenpox incidence [5], [6] and [8].

Leave a Reply

Your email address will not be published. Required fields are marked *

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>